Glutamine
Glutamine is a pharmaceutical drug with 68 clinical trials. Currently 1 active trials ongoing. Historical success rate of 73.9%.
Success Metrics
Based on 34 completed trials
Phase Distribution
Phase Distribution
10
Early Stage
21
Mid Stage
19
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
34 of 51 finished
33.3%
17 ended early
1
trials recruiting
68
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.
A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia
Efficacy of Glutamine in Management of Radiation Mucositis
Effects of Oral Care With Glutamine on Oral Health, Oral Flora and Incidence of Pneumonia After Neurosurgery With Microbiome Analysis
Glutamine and Traumatic Brain Injury
Clinical Trials (68)
Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.
A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia
Efficacy of Glutamine in Management of Radiation Mucositis
Effects of Oral Care With Glutamine on Oral Health, Oral Flora and Incidence of Pneumonia After Neurosurgery With Microbiome Analysis
Glutamine and Traumatic Brain Injury
Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis
Use of Glutamine for Recovery Muscle Strength
Glutamine Supplementation and Short-term Mortality in Covid-19
Oral Glutamine and Thoracic/Upper Aerodigestive Tumors Radiation Toxicity
Glutamine PET Imaging in LAM
Glutamine and Insulin Sensitivity in Type I Diabetes
A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers
Trial of Glutamine and Antioxidant Supplementation in Critically Ill Patients
Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Perioperative Immunonutrition, Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patients
Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma
Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype
Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib
Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
The Safety and Efficacy of TET Enema in the Treatment of UC
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 68